VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IACH 2021 | Bloodless HSCT: patient selection and practice

Bhagirathbhai Dholaria, MBBS, of Vanderbilt University Medical Center, Nashville, TN, explains the criteria used to select patients eligible for bloodless HSCT and details the process of bloodless HSCT, which includes pre-transplant optimization, G-CSF-mediated stem cell mobilisation and collection, conditioning, and monitoring. Dr Dholaria also emphasizes the importance of managing bleeding complications. This interview took place at the 4th Annual Meeting of the International Academy for Clinical Hematology (IACH), which took place virtually in 2021.

Disclosures

Bhagirathbhai Dholaria, MBBS, has received research or grant support from Janssen, Takeda, MEI, Poseida, Angiocrine and Pfizer; and has received consultation/advisory board/employment fees from Jazz Pharmaceuticals.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter